Life sciences news
-
Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure
Wednesday April 3rd 2024
Read more
-
Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy
Monday March 25th 2024
Read more
-
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
Wednesday February 28th 2024
Read more
-
Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia
Wednesday February 21st 2024
Read more
-
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Tuesday January 23rd 2024
Read more
-
KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy
Tuesday January 16th 2024
Read more
-
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
Wednesday December 20th 2023
Read more
-
argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus
Wednesday December 20th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
Wednesday December 20th 2023
Read more
-
Biotalys announces results of independent field trials in the U.S.
Tuesday December 19th 2023
Read more
-
Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial
Monday December 18th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
